Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Benznidazol (Benznidazole) 是一种抗寄生虫药物,对哥伦比亚 T. cruzi 菌株的 IC50值为 20.35 μM,有潜力研究美洲锥虫病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 108 | 现货 | ||
5 mg | ¥ 153 | 现货 | ||
10 mg | ¥ 208 | 现货 | ||
25 mg | ¥ 328 | 现货 | ||
50 mg | ¥ 496 | 现货 | ||
100 mg | ¥ 662 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 332 | 现货 |
产品描述 | Benznidazol (Benznidazole)e has an antiprotozoal activity by interfering with parasite protein biosynthesis, influencing cytokines production and stimulating host phagocytosis. |
靶点活性 | Antiparasite:20.35 μM |
体外活性 | Benznidazole inhibits the proliferation of leukemic non-adherent cells by controlling cell cycle at G0/G1 cell phase through up-regulation of p27. Growth inhibition induced by Benznidazole is a reversible process, not accompanied by significant cell death. Benznidazole also has an immunomodulatory effect on macrophages by blocking the transcription of some pro-inflammatory mediators without altering interleukin 10 expression [1]. |
体内活性 | In Wistar rats treated orally, Tmaxs of Benznidazole are 2.0 and 1.1 h, respectively. Tmaxs of 15, 30, or 60 min, depending on the dose, in BALB/c mice following intraperitoneal treatment and Tmaxs of 1 to 5 h for dogs treated orally. In mice, Benznidazole (100 mg/kg, p.o.): Tmax in plasma, 0.83 h; Cmax in plasma: 41.61 μg/ml. The elimination half-life (t1/2) of Benznidazole was 2.03 h, and mean residence time (MRT) was 3.86 h. The volume of distribution (V) and clearance (CL), both as a function of Benznidazole bioavailability (F), were 38.81 ml and 13.29 ml/h, respectively. Benznidazole can cross the blood-brain barrier and exert its action in cases of central nervous system parasitism. However, other studies have indicated that BNZ has toxic effects in the central nervous system. Dogs orally treated with BNZ presented encephalopathy with multifocal characteristics and clinical, pathological, and neurological disorders that were dose-dependent and time-dependent. Benznidazole biodistribution occurs broadly, reaching the heart and colon, which are the most relevant organs for T. cruzi infection, and also the spleen, brain, liver, lungs, and kidneys [2]. |
细胞实验 | 20000 THP-1 cells in 200 mL of complete medium were incubated in quadruplicate in a 96-well plate in the presence of BZL (0.1, 0.5 and 1 mM) or vehicle (0.1% DMSO) for 24 or 48 h and then 20 mL of MTT solution (5 mg/mL in phosphate-buffered saline [PBS]) was added to each well. After 2 h at 37 °C, the MTT solution was removed and precipitated formazan was solubilized in 200 mL DMSO. Formazan production was then measured at OD545nm in a microplate spectrophotometer, with DMSO as blank. |
别名 | 苄哒唑, 苄硝唑, Radanil, Benznidazole, Ro 71051, Ro 07-1051 |
分子量 | 260.25 |
分子式 | C12H12N4O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methanol: 50 mg/mL
DMSO: 60 mg/mL (230.55 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.8425 mL | 19.2123 mL | 38.4246 mL | 96.0615 mL |
5 mM | 0.7685 mL | 3.8425 mL | 7.6849 mL | 19.2123 mL | |
10 mM | 0.3842 mL | 1.9212 mL | 3.8425 mL | 9.6061 mL | |
20 mM | 0.1921 mL | 0.9606 mL | 1.9212 mL | 4.8031 mL | |
50 mM | 0.0768 mL | 0.3842 mL | 0.7685 mL | 1.9212 mL | |
100 mM | 0.0384 mL | 0.1921 mL | 0.3842 mL | 0.9606 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Benznidazol Microbiology/Virology Antibiotic Parasite Ro71051 苄哒唑 苄硝唑 inhibit Radanil Benznidazole Ro 71051 Inhibitor Ro-71051 Ro 07-1051 inhibitor